The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10517 malaria professionals are enjoying the free benefits of MalariaWorld today

MESA; malaria; ACT

Webinar 'Evaluating antimalarial safety' from ACT consortium, Oct 7th 2014

September 30, 2014 - 14:33 -- MalariaWorld Events

Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.

Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV.

Webinar 'Evaluating antimalarial safety' from ACT consortium, Oct 7th 2014

September 30, 2014 - 14:07 -- MESA Alliance

Clinical trials are not suitable to identify rare, potentially serious adverse effects of drugs, or to define their safety in high risk populations.

Artemisinin-based combination therapies (or ACTs) are considered safe, but there are concerns over their potential to cause damage to parts of the brain. There is also a concern about their safety in patients infected with HIV. 

Subscribe to RSS - MESA; malaria; ACT